FDA Pharmocogenomic Data Guidance To Be Finalized By Year-End

FDA will issue a final guidance on pharmacogenomic data submissions later this year, Center for Drug Evaluation & Research Acting Director Steven Galson, MD, told the Biotechnology Industry Organization annual meeting in San Francisco